Clinical Trials
24 trialsSATIATION
University Hospital, Brest
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer Survivors
Queen's University, Belfast
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity
University College, London
PC-TOX
University College, London
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
Ain Shams University
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
Ain Shams University
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
University Hospital, Essen
EIECC
Qianfoshan Hospital
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude
Affiliated Hospital of Qinghai University
Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol
Ultromics Ltd
Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy
University of Glasgow
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy
Military Institute od Medicine National Research Institute
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Peking University Third Hospital
Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab
Peking University Third Hospital
AI
Taipei Medical University Shuang Ho Hospital
Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
Second Affiliated Hospital, School of Medicine, Zhejiang University
EARLY-CATCH
Radboud University Medical Center
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Stony Brook University
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unity Health Toronto
Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine
Fondazione del Piemonte per l'Oncologia
PULSE-ECCho
McGill University Health Centre/Research Institute of the McGill University Health Centre
Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes
Rambam Health Care Campus
TOXTAC
Radboud University Medical Center